Adagio Medical Holdings, Inc. CFO Stock Option Grant
2025-09-30SEC Filing 3 (0001104659-25-094666)
Adagio Medical Holdings, Inc. (ADGM) filed a Form 3 with the SEC on September 30, 2025, reporting a stock option grant to Deborah Kaster, the company's Chief Financial Officer. The filing details an employee stock option grant for the right to buy 728,000 shares of common stock at an exercise price of $0.84 per share. The options have an expiration date of April 1, 2035. Vesting for the options begins on April 1, 2026, with 25% of the shares vesting on the one-year anniversary of this date, followed by 36 equal monthly installments for the remaining shares. The filing indicates that Deborah Kaster holds these options directly.
Tickers mentioned in this filing:ADGM
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/2006986/0001104659-25-094666.txt